Yoshimi Mizuno
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.
Journal: British journal of haematology
Published: February 22, 2020
Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
Journal: Experimental hematology
Published: January 19, 2020
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach.
Journal: Cancer genomics & proteomics
Published: October 04, 2019
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma.
Journal: International journal of hematology
Published: November 26, 2018
Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab.
Journal: Infection and drug resistance
Published: May 23, 2018
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Journal: Investigational new drugs
Published: May 10, 2018
Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline.
Journal: Cancer genomics & proteomics
Published: February 19, 2018
Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.
Journal: Cancer medicine
Published: September 13, 2017
Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Journal: Experimental hematology
Published: July 31, 2017
Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody.
Journal: Internal medicine (Tokyo, Japan)
Published: August 16, 2016
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy.
Journal: Annals of hematology
Published: August 06, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026